Asia Pacific Sepsis Diagnostics Market Forecast to 2028

Report Code : BMIRE00025658 | Region : Asia Pacific | Industry : Medical Device | Published Date : 14/Feb/2023
Asia Pacific Sepsis Diagnostics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Instruments, Reagents and Assays, Blood Culture Media, and Software), Technology (Molecular Diagnostics {Polymerase Chain Reaction, Peptide Nucleic Acid-Fluorescent in Situ Hybridization, Syndromic Panel-Based Testing, Microarrays}, Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, and Microbiology), Method (Automated Diagnostics and Conventional Diagnostics), Test Type (Point-of-Care Tests and Laboratory Tests), Pathogen (Bacterial Sepsis, Fungal Sepsis, and Others), and End User (Hospitals, Pathology and Reference Laboratories, and Others)

The Asia Pacific sepsis diagnostics market is expected to grow from US$ 131.79 million in 2021 to US$ 249.70 million by 2028. It is estimated to record a CAGR of 9.6% from 2021 to 2028.

Increase in Funding and Support for Sepsis Diagnostics Research to Bolster Asia Pacific Sepsis Diagnostics Market Growth During Forecast Period

The rising need for rapid diagnostics for sepsis fueled the research activities by key players in recent years. Existing players and start-ups in sepsis diagnostics are well supported financially by government and research organizations. In April 2020, Cytovale Inc. announced its partnership with the Biomedical Advanced Research and Development Authority (BARDA) for sepsis diagnosis in patients suffering from infectious respiratory diseases, including COVID-19. The research was estimated to stand at US$ 5.9 million, with a contribution of ~ US$ 3.83 million by BARDA.

Additionally, the National Institute of General Medical Sciences (NIGMS) intends to use the NIH SBIR/STTR program to support preclinical and clinical sepsis studies to develop improved diagnostic tools and therapies. Diagnostics companies are continuously securing funding to establish rapid sepsis diagnostic tests. For instance, in June 2021, HelixBind secured a US$ 3 million grant from the National Institutes of Health (NIH) to support the testing of its rapid diagnostic platform for invasive infections associated with sepsis. The financial support aided the research and led to the evolution of novel biomarkers for sepsis diagnosis. Biomarkers offer a tool for facilitating early diagnosis, identifying patient populations at high risk of complications, and monitoring the disease's progression, which are critical assessments for appropriate therapy and improvement in patient outcomes. Also, the launch of effective treatments and ongoing clinical trials will provide beneficial opportunities for the Asia Pacific sepsis diagnostics market during the forecast period.

Asia Pacific Sepsis Diagnostics Market Overview

The Asia Pacific sepsis diagnostics market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The market growth in Asia Pacific countries is attributed to rising healthcare expenditure, rapid economic development in countries such as India and China, increasing prevalence of sepsis, and rising utilization of novel techniques. However, inadequate reimbursements and rising healthcare costs reduce the use of novel diagnostic techniques, which restrains the market growth.

Asia Pacific Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Sepsis Diagnostics Market Segmentation

The Asia Pacific sepsis diagnostics market is segmented on the basis of product, technology, method, test type, pathogen, end user, and country.

Based on product, the Asia Pacific sepsis diagnostics market is segmented into instruments, reagents and assays, blood culture media, and software. The blood culture media segment held the largest market share in 2021.

Based on technology, the Asia Pacific sepsis diagnostics market is segmented into molecular diagnostics, flow cytometry, microfluidics, immunoassay, biomarkers, and microbiology. The microbiology segment held the largest market share in 2021. The market for the molecular diagnostics segment is sub segmented into polymerase chain reaction, peptide nucleic acid-fluorescent in situ hybridization, syndromic panel-based testing, and microarrays.

Based on method, the Asia Pacific sepsis diagnostics market is bifurcated into automated diagnostics and conventional diagnostics. The conventional diagnostics segment held a larger market share in 2021.

Based on test type, the Asia Pacific sepsis diagnostics market is bifurcated into point-of-care tests and laboratory tests. The laboratory tests segment held a larger market share in 2021.

Based on pathogen, the Asia Pacific sepsis diagnostics market is segmented into bacterial sepsis, fungal sepsis, and others. The bacterial sepsis segment held the largest market share in 2021.

Based on end user, the Asia Pacific sepsis diagnostics market is segmented into hospitals, pathology and reference laboratories, and others. The hospitals segment held the largest market share in 2021.

Based on country, the Asia Pacific sepsis diagnostics market is segmented into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. China dominated the market share in 2021.

Abbott; BD; bioMerieux SA; Danaher (Beckman Coulter); F. HOFFMANN-LA ROCHE LTD.; Immunexpress Inc.; Luminex Corporation; T2 Biosystems, Inc.; and THERMO FISHER SCIENTIFIC INC. are among the leading companies operating in the Asia Pacific sepsis diagnostics market.

The List of Companies - Asia Pacific Sepsis Diagnostics Market

● Abbott

● BD

● bioMerieux SA

● Danaher (Beckman Coulter)

● F. HOFFMANN-LA ROCHE LTD.

● Immunexpress Inc.

● Luminex Corporation

● T2 Biosystems, Inc.

● THERMO FISHER SCIENTIFIC INC.

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Asia Pacific Sepsis Diagnostics Market – By Product

1.3.2 Asia Pacific Sepsis Diagnostics Market – By Technology

1.3.3 Asia Pacific Sepsis Diagnostics Market – By Method

1.3.4 Asia Pacific Sepsis Diagnostics Market – By Test Type

1.3.5 Asia Pacific Sepsis Diagnostics Market – By Pathogen

1.3.6 Asia Pacific Sepsis Diagnostics Market – By End User

1.3.7 Asia Pacific Sepsis Diagnostics Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Asia Pacific Sepsis Diagnostics Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Asia Pacific PEST Analysis

4.3 Experts Opinion

5. Asia Pacific Sepsis Diagnostics Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 High Incidence of Sepsis due to Increasing Nosocomial Infections

5.1.2 Rise in Demand for Rapid Diagnostic Tests Leading to Increasing Product Launches

5.2 Market Restraints

5.2.1 Lack of Skilled Professionals

5.3 Market Opportunities

5.3.1 Increase in Funding and Support for Sepsis Diagnostics Research

5.4 Future Trends

5.4.1 Rising Technological Advancements in Sepsis Diagnosis

5.5 Impact Analysis

6. Sepsis Diagnostics Market–Asia Pacific Analysis

6.1 Asia Pacific Sepsis Diagnostics Market Revenue Forecast and Analysis

7. Asia Pacific Sepsis Diagnostics Market Revenue and Forecasts To 2028– by Product

7.1 Overview

7.2 Asia Pacific Sepsis Diagnostics Market, By Product, 2021 & 2028 (%)

7.3 Instruments

7.3.1 Overview

7.3.2 Instruments: Asia Pacific Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.4 Reagents and Assays

7.4.1 Overview

7.4.2 Reagents and Assays: Asia Pacific Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.5 Blood Culture Media

7.5.1 Overview

7.5.2 Blood Culture Media: Asia Pacific Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.6 Software

7.6.1 Overview

7.6.2 Software: Asia Pacific Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

8. Asia Pacific Sepsis Diagnostics Market Revenue and Forecasts To 2028 – Technology

8.1 Overview

8.2 Asia Pacific Sepsis Diagnostics Market Share by Technology - 2021 & 2028 (%)

8.3 Molecular Diagnostics

8.3.1 Overview

8.3.2 Molecular Diagnostics: Asia Pacific Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.2.1 Polymerase Chain Reaction

8.3.2.1.1 Overview

8.3.2.1.2 Polymerase Chain Reaction: Asia Pacific Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.2.2 Peptide Nucleic Acid-Fluorescent in Situ Hybridization

8.3.2.2.1 Overview

8.3.2.2.2 Peptide Nucleic Acid-Fluorescent in Situ Hybridization: Asia Pacific Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.2.3 Syndromic Panel-Based Testing

8.3.2.3.1 Overview

8.3.2.3.2 Syndromic Panel-Based Testing: Asia Pacific Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.2.4 Microarrays

8.3.2.4.1 Overview

8.3.2.4.2 Microarrays: Asia Pacific Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.4 Flow Cytometry

8.4.1 Overview

8.4.2 Flow Cytometry: Asia Pacific Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.4.3 Real-Time Cell Analysis

8.4.3.1 TaqMan-Based Multiplex RT PCR and Blood Culture

8.4.3.1.1 Characteristics of TaqMan Assays

8.4.3.2 Magicplex (TM)Sepsis Real-Time Tests Performed in Tertiary Regina Margherita Children's Hospital (Turin, Italy) – Case Study

8.4.3.2.1 Abstract

8.4.3.2.2 Conclusion:

8.4.3.3 Companies that are engaged in providing Sepsis Diagnostic solutions

8.4.3.4 Sepsis diagnosis by real-time PCR

8.4.3.5 New next-generation sequencing technique and technological advancements/innovations

8.4.3.6 Real Time Cellular Analysis Using Impedance Measurements

8.4.4 Real-Time Cell Analysis: Asia Pacific Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.5 Microfluidics

8.5.1 Overview

8.5.2 Microfluidics: Asia Pacific Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.6 Immunoassay

8.6.1 Overview

8.6.2 Immunoassay: Asia Pacific Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.7 Biomarkers

8.7.1 Overview

8.7.2 Biomarkers: Asia Pacific Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.7.3 Metabolomics

8.7.3.1 Metabolite Profile in Sepsis

8.7.3.2 Penetration/Usage Pattern of Metabolomics in Sepsis Diagnosis

8.7.3.3 Early Prediction of Sepsis by Metabolite Profiling

8.7.3.4 Future Role of Omics in Diagnosis and Therapy of Sepsis

8.7.3.4.1 Genomics

8.7.3.4.2 Proteomics

8.7.3.5 Sepsis Biomarkers and Diagnostic Tools

8.7.3.6 Role Metabolomics and Proteomics in Sepsis

8.7.3.7 Potential Approach for Identifying Small Molecule Biomarkers for Acute Kidney Disease Prognosis

8.7.3.8 Recent Application of Metabolomics in Sepsis Diagnosis

8.7.3.9 Metabolics in Mitochondrial Function

8.7.3.10 Substantial Potential of Metabolomics in Diagnostics for Mitochondrial Medicine

8.7.4 Metabolomics: Asia Pacific Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.8 Microbiology

8.8.1 Overview

8.8.2 Microbiology: Asia Pacific Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9. Asia Pacific Sepsis Diagnostics Market Revenue and Forecasts To 2028 – Method

9.1 Overview

9.2 Asia Pacific Sepsis Diagnostics Market Share by Method - 2021 & 2028 (%)

9.3 Automated Diagnostics

9.3.1 Overview

9.3.2 Automated Diagnostics: Asia Pacific Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.4 Conventional Diagnostics

9.4.1 Overview

9.4.2 Conventional Diagnostics: Asia Pacific Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10. Asia Pacific Sepsis Diagnostics Market Revenue and Forecasts To 2028 – Test Type

10.1 Overview

10.2 Asia Pacific Sepsis Diagnostics Market Share by Test Type - 2021 & 2028 (%)

10.3 Point-of-Care Tests

10.3.1 Overview

10.3.2 Point-of-Care Tests: Asia Pacific Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10.4 Laboratory Tests

10.4.1 Overview

10.4.2 Laboratory Tests: Asia Pacific Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

11. Asia Pacific Sepsis Diagnostics Market Revenue and Forecasts To 2028 – Pathogen

11.1 Overview

11.2 Asia Pacific Sepsis Diagnostics Market Share by Pathogen - 2021 & 2028 (%)

11.3 Bacterial Sepsis

11.3.1 Overview

11.3.2 Bacterial Sepsis: Asia Pacific Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

11.4 Fungal Sepsis

11.4.1 Overview

11.4.2 Fungal Sepsis: Asia Pacific Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

11.5 Others

11.5.1 Overview

11.5.2 Others: Asia Pacific Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

12. Asia Pacific Sepsis Diagnostics Market Revenue and Forecasts To 2028 – End User

12.1 Overview

12.2 Asia Pacific Sepsis Diagnostics Market Share by End User - 2021 & 2028 (%)

12.3 Hospitals

12.3.1 Overview

12.3.2 Hospitals: Asia Pacific Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

12.4 Pathology and Reference Laboratories

12.4.1 Overview

12.4.2 Pathology and Reference Laboratories: Asia Pacific Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

12.5 Others

12.5.1 Overview

12.5.2 Others: Asia Pacific Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

13. Asia Pacific Sepsis Diagnostics Market Revenue and Forecasts to 2028 –Country Analysis

13.1 Overview

13.1.1 Asia Pacific Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)

13.1.1.1 China: Asia Pacific Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

13.1.1.1.1 China: Asia Pacific Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

13.1.1.1.2 China: Asia Pacific Sepsis Diagnostics Market, By Product, 2019–2028 (USD Million)

13.1.1.1.3 China: Asia Pacific Sepsis Diagnostics Market, by Technology, 2019–2028 (USD Million)

13.1.1.1.3.1 Biomarkers: Metabolomics 2019-2028

13.1.1.1.3.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028

13.1.1.1.3.3 China Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)

13.1.1.1.4 China: Asia Pacific Sepsis Diagnostics Market, by Method, 2019–2028 (USD Million)

13.1.1.1.5 China: Asia Pacific Sepsis Diagnostics Market, by Test Type, 2019–2028 (USD Million)

13.1.1.1.6 China: Asia Pacific Sepsis Diagnostics Market, by Pathogen, 2019–2028 (USD Million)

13.1.1.1.7 China: Asia Pacific Sepsis Diagnostics Market, By End User, 2019–2028 (USD Million)

13.1.1.2 Japan: Asia Pacific Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

13.1.1.2.1 Japan: Asia Pacific Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

13.1.1.2.2 Japan: Asia Pacific Sepsis Diagnostics Market, By Product, 2019–2028 (USD Million)

13.1.1.2.3 Japan: Asia Pacific Sepsis Diagnostics Market, By Technology, 2019–2028 (USD Million)

13.1.1.2.3.1 Biomarkers: Metabolomics 2019-2028

13.1.1.2.3.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028

13.1.1.2.3.3 Japan Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)

13.1.1.2.4 Japan: Asia Pacific Sepsis Diagnostics Market, By Method, 2019–2028 (USD Million)

13.1.1.2.5 Japan: Asia Pacific Sepsis Diagnostics Market, By Test Type, 2019–2028 (USD Million)

13.1.1.2.6 Japan: Asia Pacific Sepsis Diagnostics Market, By Pathogen, 2019–2028 (USD Million)

13.1.1.2.7 Japan: Asia Pacific Sepsis Diagnostics Market, By End User, 2019–2028 (USD Million)

13.1.1.3 India: Asia Pacific Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

13.1.1.3.1 India: Asia Pacific Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

13.1.1.3.2 India: Asia Pacific Sepsis Diagnostics Market, By Product, 2019–2028 (USD Million)

13.1.1.3.3 India: Asia Pacific Sepsis Diagnostics Market, By Technology, 2019–2028 (USD Million)

13.1.1.3.3.1 Biomarkers: Metabolomics 2019-2028

13.1.1.3.3.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028

13.1.1.3.3.3 India Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)

13.1.1.3.4 India: Asia Pacific Sepsis Diagnostics Market, By Method, 2019–2028 (USD Million)

13.1.1.3.5 India: Asia Pacific Sepsis Diagnostics Market, By Test Type, 2019–2028 (USD Million)

13.1.1.3.6 India: Asia Pacific Sepsis Diagnostics Market, By Pathogen, 2019–2028 (USD Million)

13.1.1.3.7 India: Asia Pacific Sepsis Diagnostics Market, By End User, 2019–2028 (USD Million)

13.1.1.4 Australia: Asia Pacific Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

13.1.1.4.1 Australia: Asia Pacific Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

13.1.1.4.2 Australia: Asia Pacific Sepsis Diagnostics Market, By Product, 2019–2028 (USD Million)

13.1.1.4.3 Australia: Asia Pacific Sepsis Diagnostics Market, By Technology, 2019–2028 (USD Million)

13.1.1.4.3.1 Biomarkers: Metabolomics 2019-2028

13.1.1.4.3.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028

13.1.1.4.3.3 Australia Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)

13.1.1.4.4 Australia: Asia Pacific Sepsis Diagnostics Market, By Method, 2019–2028 (USD Million)

13.1.1.4.5 Australia: Asia Pacific Sepsis Diagnostics Market, By Test Type, 2019–2028 (USD Million)

13.1.1.4.6 Australia: Asia Pacific Sepsis Diagnostics Market, By Pathogen, 2019–2028 (USD Million)

13.1.1.4.7 Australia: Asia Pacific Sepsis Diagnostics Market, By End User, 2019–2028 (USD Million)

13.1.1.5 South Korea: Asia Pacific Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

13.1.1.5.1 South Korea: Asia Pacific Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

13.1.1.5.2 South Korea: Asia Pacific Sepsis Diagnostics Market, By Product, 2019–2028 (USD Million)

13.1.1.5.3 South Korea: Asia Pacific Sepsis Diagnostics Market, By Technology, 2019–2028 (USD Million)

13.1.1.5.3.1 Biomarkers: Metabolomics 2019-2028

13.1.1.5.3.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028

13.1.1.5.3.3 South Korea Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)

13.1.1.5.4 South Korea: Asia Pacific Sepsis Diagnostics Market, By Method, 2019–2028 (USD Million)

13.1.1.5.5 South Korea: Asia Pacific Sepsis Diagnostics Market, By Test Type, 2019–2028 (USD Million)

13.1.1.5.6 South Korea: Asia Pacific Sepsis Diagnostics Market, By Pathogen, 2019–2028 (USD Million)

13.1.1.5.7 South Korea: Asia Pacific Sepsis Diagnostics Market, By End User, 2019–2028 (USD Million)

13.1.1.6 Rest of Asia Pacific Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

13.1.1.6.1 Rest of Asia Pacific Sepsis Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

13.1.1.6.2 Rest of Asia Pacific Sepsis Diagnostics Market, By Product, 2019–2028 (USD Million)

13.1.1.6.3 Rest of Asia Pacific Sepsis Diagnostics Market, By Technology, 2019–2028 (USD Million)

13.1.1.6.3.1 Biomarkers: Metabolomics 2019-2028

13.1.1.6.3.2 Flow Cytometry: Real-Time Cell Analysis 2019-2028

13.1.1.6.3.3 Rest of APAC Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)

13.1.1.6.4 Rest of Asia Pacific Sepsis Diagnostics Market, By Method, 2019–2028 (USD Million)

13.1.1.6.5 Rest of Asia Pacific Sepsis Diagnostics Market, By Test Type, 2019–2028 (USD Million)

13.1.1.6.6 Rest of Asia Pacific Sepsis Diagnostics Market, By Pathogen, 2019–2028 (USD Million)

13.1.1.6.7 Rest of Asia Pacific Sepsis Diagnostics Market, By End User, 2019–2028 (USD Million)

14. Sepsis Diagnostics Market–Industry Landscape

14.1 Overview

14.2 Growth Strategies in the Sepsis Diagnostics Market (%)

14.3 Organic Developments

14.3.1 Overview

14.4 Inorganic Developments

14.4.1 Overview

15. Company Profiles

15.1 Abbott

15.1.1 Key Facts

15.1.2 Business Description

15.1.3 Products and Services

15.1.4 Financial Overview

15.1.5 SWOT Analysis

15.1.6 Key Developments

15.2 F. HOFFMANN-LA ROCHE LTD.

15.2.1 Key Facts

15.2.2 Business Description

15.2.3 Products and Services

15.2.4 Financial Overview

15.2.5 SWOT Analysis

15.2.6 Key Developments

15.3 Immunexpress Inc.

15.3.1 Key Facts

15.3.2 Business Description

15.3.3 Products and Services

15.3.4 Financial Overview

15.3.5 SWOT Analysis

15.3.6 Key Developments

15.4 BD

15.4.1 Key Facts

15.4.2 Business Description

15.4.3 Products and Services

15.4.4 Financial Overview

15.4.5 SWOT Analysis

15.4.6 Key Developments

15.5 Danaher (Beckman Coulter)

15.5.1 Key Facts

15.5.2 Business Description

15.5.3 Products and Services

15.5.4 Financial Overview

15.5.5 SWOT Analysis

15.5.6 Key Developments

15.6 Luminex Corporation

15.6.1 Key Facts

15.6.2 Business Description

15.6.3 Products and Services

15.6.4 Financial Overview

15.6.5 SWOT Analysis

15.6.6 Key Developments

15.7 THERMO FISHER SCIENTIFIC INC.

15.7.1 Key Facts

15.7.2 Business Description

15.7.3 Products and Services

15.7.4 Financial Overview

15.7.5 SWOT Analysis

15.7.6 Key Developments

15.8 bioMerieux SA

15.8.1 Key Facts

15.8.2 Business Description

15.8.3 Products and Services

15.8.4 Financial Overview

15.8.5 SWOT Analysis

15.8.6 Key Developments

15.9 T2 Biosystems, Inc.

15.9.1 Key Facts

15.9.2 Business Description

15.9.3 Products and Services

15.9.4 Financial Overview

15.9.5 SWOT Analysis

15.9.6 Key Developments

16. Appendix

16.1 About the Insight Partners

16.2 Glossary of Terms

LIST OF TABLES.

Table 1. New next-generation sequencing techniques by Company

Table 2. China: Asia Pacific Sepsis Diagnostics Market, By Product – Revenue and Forecast to 2028 (USD Million)

Table 3. China: Asia Pacific Sepsis Diagnostics Market, by Technology– Revenue and forecast to 2028 (USD Million)

Table 4. China: Asia Pacific Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and forecast to 2028 (USD Million)

Table 5. China: Asia Pacific Sepsis Diagnostics Market, by Method– Revenue and forecast to 2028 (USD Million)

Table 6. China: Asia Pacific Sepsis Diagnostics Market, by Test Type– Revenue and forecast to 2028 (USD Million)

Table 7. China: Asia Pacific Sepsis Diagnostics Market, by Pathogen – Revenue and forecast to 2028 (USD Million)

Table 8. China: Asia Pacific Sepsis Diagnostics Market, By End User– Revenue and Forecast to 2028 (USD Million)

Table 9. Japan: Asia Pacific Sepsis Diagnostics Market, By Product – Revenue and Forecast to 2028 (USD Million)

Table 10. Japan: Asia Pacific Sepsis Diagnostics Market, By Technology – Revenue and Forecast to 2028 (USD Million)

Table 11. Japan: Asia Pacific Sepsis Diagnostics Market, By Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)

Table 12. Japan: Asia Pacific Sepsis Diagnostics Market, By Method – Revenue and Forecast to 2028 (USD Million)

Table 13. Japan: Asia Pacific Sepsis Diagnostics Market, By Test Type – Revenue and Forecast to 2028 (USD Million)

Table 14. Japan: Asia Pacific Sepsis Diagnostics Market, By Pathogen – Revenue and Forecast to 2028 (USD Million)

Table 15. Japan: Asia Pacific Sepsis Diagnostics Market, By End User– Revenue and Forecast to 2028 (USD Million)

Table 16. India: Asia Pacific Sepsis Diagnostics Market, By Product– Revenue and Forecast to 2028(USD Million)

Table 17. India: Asia Pacific Sepsis Diagnostics Market, By Technology – Revenue and Forecast to 2028 (USD Million)

Table 18. India: Asia Pacific Sepsis Diagnostics Market, By Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)

Table 19. India: Asia Pacific Sepsis Diagnostics Market, By Method – Revenue and Forecast to 2028 (USD Million)

Table 20. India: Asia Pacific Sepsis Diagnostics Market, By Test Type – Revenue and Forecast to 2028 (USD Million)

Table 21. India: Asia Pacific Sepsis Diagnostics Market, By Pathogen – Revenue and Forecast to 2028 (USD Million)

Table 22. India: Asia Pacific Sepsis Diagnostics Market, By End User– Revenue and Forecast to 2028 (USD Million)

Table 23. Australia: Asia Pacific Sepsis Diagnostics Market, By Product – Revenue and Forecast to 2028 (USD Million)

Table 24. Australia: Asia Pacific Sepsis Diagnostics Market, By Technology – Revenue and Forecast to 2028 (USD Million)

Table 25. Australia: Asia Pacific Sepsis Diagnostics Market, By Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)

Table 26. Australia: Asia Pacific Sepsis Diagnostics Market, By Method – Revenue and Forecast to 2028 (USD Million)

Table 27. Australia: Asia Pacific Sepsis Diagnostics Market, By Test Type – Revenue and Forecast to 2028 (USD Million)

Table 28. Australia: Asia Pacific Sepsis Diagnostics Market, By Pathogen – Revenue and Forecast to 2028 (USD Million)

Table 29. Australia: Asia Pacific Sepsis Diagnostics Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 30. South Korea: Asia Pacific Sepsis Diagnostics Market, By Product – Revenue and Forecast to 2028 (USD Million)

Table 31. South Korea: Asia Pacific Sepsis Diagnostics Market, By Technology – Revenue and Forecast to 2028 (USD Million)

Table 32. South Korea: Asia Pacific Sepsis Diagnostics Market, By Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)

Table 33. South Korea: Asia Pacific Sepsis Diagnostics Market, By Method – Revenue and Forecast to 2028 (USD Million)

Table 34. South Korea: Asia Pacific Sepsis Diagnostics Market, By Test Type – Revenue and Forecast to 2028 (USD Million)

Table 35. South Korea: Asia Pacific Sepsis Diagnostics Market, By Pathogen – Revenue and Forecast to 2028 (USD Million)

Table 36. South Korea: Asia Pacific Sepsis Diagnostics Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 37. Rest of Asia Pacific Sepsis Diagnostics Market, By Product – Revenue and Forecast to 2028 (USD Million)

Table 38. Rest of Asia Pacific Sepsis Diagnostics Market, By Technology– Revenue and Forecast to 2028 (USD Million)

Table 39. Rest of Asia Pacific Sepsis Diagnostics Market, By Molecular Diagnostics – Revenue and Forecast to 2028 (USD Million)

Table 40. Rest of Asia Pacific Sepsis Diagnostics Market, By Method– Revenue and Forecast to 2028 (USD Million)

Table 41. Rest of Asia Pacific Sepsis Diagnostics Market, By Test Type– Revenue and Forecast to 2028 (USD Million)

Table 42. Rest of Asia Pacific Sepsis Diagnostics Market, By Pathogen– Revenue and Forecast to 2028 (USD Million)

Table 43. Rest of Asia Pacific Sepsis Diagnostics Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 44. Recent Organic Growth Strategies in Sepsis Diagnostics Market

Table 45. Inorganic Developments in the Sepsis Diagnostics Market

Table 46. Glossary of Terms

The List of Companies - Asia Pacific Sepsis Diagnostics Market

● Abbott

● BD

● bioMerieux SA

● Danaher (Beckman Coulter)

● F. HOFFMANN-LA ROCHE LTD.

● Immunexpress Inc.

● Luminex Corporation

● T2 Biosystems, Inc.

● THERMO FISHER SCIENTIFIC INC.

Reason To Buy

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific sepsis diagnostics market.

● Highlights key business priorities in order to assist companies to realign their business strategies.

● The key findings and recommendations highlight crucial progressive industry trends in Asia Pacific sepsis diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

● Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.

● Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

AVAILABLE CUSTOMIZATION RESEARCH METHODOLOGY REQUEST FOR TOC FREE SAMPLE REPORT
CHOOSE LICENCE TYPE
(Asia Pacific Sepsis Diagnostics Market Forecast to 2028)
  • Single User Price $3,000$2,400
  • Site Price $4,000$3,200
  • Enterprise Price $5,000$4,000
Buy Now Add to Cart
REQUEST FOR TOC
SPEAK TO ANALYST
FREE SAMPLE
REPORT
INQUIRE BEFORE
BUYING
TOP
Quick Enquiry